Alpha Aesthetics Partners, a Thurston Group portfolio company, is redefining the medical aesthetics industry. As the premier network of medical spas, Alpha empowers providers and practice partners ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication ...

Alhemo Approved for Treatment of Hemophilia A or B With Inhibitors Ryoncil (remestemcel-L-rknd) Allogeneic bone marrow-derived mesenchymal stromal cell therapy Treatment of steroid-refractory ...

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

VERVE Medical Cosmetics, New York's premier non-surgical medical spa and anti-aging treatment studio has been helping clients manage the aging process with immediate, natural results. As he celebrates ...

在细胞治疗的研究浪潮中，间充质基质细胞（MSCs）是关键的研究对象。但患者年龄及细胞获取困难等问题制约其临床应用。近日，发表在 Life Sci 的一项研究 iPSC-derived mesenchymal stromal cells ...

Mesoblast shares fall ~7% despite a $260 million placement following FDA approval for its cell therapy treatment ...

The Mesoblast Ltd (ASX: MSB) share price is catching the eye of investors on Tuesday. Why are its shares being hammered?

Morphological profiling allows accurate identification of cell types in dense iPSC-derived cultures, allowing its use for quality control and differentiation monitoring.